Derived from the ASAlaser educational experience and from an open dialogue with professionals already employing the Hilterapia®, the MLS® Laser Therapy or the Magnetotherapy, the “global approach” method favours the simultaneous treatment of the affected area and of the related zones – often the subject of further problems such as contractures and trigger points, where present -, reducing pain from the first session and stimulating a full and fast recovery. “Our studies and our training – explains Alberto Zaghetto, the ASAlaser training coordinator – have demonstrated that the use of our therapies with a global approach already leads to results from the first treatment”. As the ASAlaser methodology has an evident beneficial action in respect of the inflammation and the consequent problems as well as on the pain, this allows unlocking – and resolving – all biomechanical dysfunctions which generate mobility problems and lower the patient’s quality of life. This ensures it is a particularly useful instrument for rehabilitation therapy allowing a gradual and constant improvement of the patient’s condition, up to complete healing. The global approach therapeutic treatment may be applied with all ASA apparatuses and maximises the obtainable results thanks to a designed distribution of the irradiated energy throughout the muscles which are directly and indirectly involved in the movement which causes pain. “For example, in the case of Hilterapia® - explains Zaghetto - the total energy indicated for the treatment is homogeneously distributed with 60% in the muscle area and the remaining 40% in the area of the injury or pathology and the pain radiation area. As a consequence, in addition to quickly reducing the pain symptoms, a rapid solution to the problem which caused the patient to contact the professional is obtained”.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.